Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest. A ...

Groups of districts already working on escaping the factory model applied for grant money to work on innovative high school ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

The group of lifelong intestinal conditions known as inflammatory bowel disease (IBD), which includes Crohn's disease and ...

The Germany 3D bioprinted human tissue market is on the cusp of a transformative decade, projected to grow from USD 70.7 ...

This California high school features multi-hour labs that blend topics and the curriculum is tailored to students’ interests.

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...